Skip to main content
. 2007 Nov 15;1:21. doi: 10.1186/1751-0759-1-21

Table 4.

Changes in GSRS scores by FLV and FLV+TJ-43 treatment.

GSRS score pre-treatment post-treatment
Total
 FLV 2.42 ± 1.24 2.52 ± 0.99 n.s.
 FLV+TJ-43 2.45 ± 1.10 1.97 ± 0.81 *
Reflux
 FLV 2.13 ± 1.46 2.50 ± 1.35 n.s.
 FLV+TJ-43 2.37 ± 1.61 2.00 ± 0.91 n.s.
Abdominal pain
 FLV 2.63 ± 1.56 3.18 ± 1.81 n.s.
 FLV+TJ-43 3.03 ± 1.82 2.18 ± 1.00 +
Indigestion
 FLV 1.70 ± 0.97 1.87 ± 0.74 n.s.
 FLV+TJ-43 2.05 ± 0.95 1.78 ± 1.06 n.s.
Diarrhea
 FLV 2.87 ± 1.78 2.35 ± 1.60 n.s.
 FLV+TJ-43 2.25 ± 1.47 1.65 ± 1.06 +
Constipation
 FLV 2.64 ± 1.87 2.83 ± 1.33 n.s.
 FLV+TJ-43 2.66 ± 1.69 2.34 ± 1.53 n.s.

FLV = fluvoxamine; TJ-43 = Rikkunshito. mean ± SD. * p < 0.05, + p < 0.1 by paired t-test.